ENTITY

AstraZeneca (AZN SS)

31
Analysis
Health CareUnited Kingdom
AstraZeneca PLC operates as a holding company. The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.
more
21 Nov 2016 15:45

Andrew on Tech: IOT Everywhere

The proliferation of IoT: With over 25% 5-year CAGR for IoT devices shipment and wafer foundry market but a very fragmented vendors list, we...

Logo
Andrew Lu
326 Views
Share
bullishImmune Design
16 Nov 2016 07:37

New Long Position: 'Red Bull' like Immune Boost Against Cancer

Immune Design Corp (IMDZ US) is an emerging immuno-oncology company (based in Seattle, Washington) that is using its proprietary technology in...

15 Nov 2016 07:01

Contrarian Idea of the Day: Long Dynavax Technologies (DVAX US)

Dynavax Technologies (DVAX) common stock plunged today after receiving a complete response letter (CRL) from FDA regarding its approval...

13 Nov 2016 08:19

Five More Actionable Ideas in a Post-Trump World

Summary: These include: Short U.S. treasury bonds, short emerging markets (but long Russia equity index), long U.S. dollar and short Euro. Apart...

11 Nov 2016 12:05

President Trump and Healthcare (And Pharma) Sector: What's Next?

Now that the initial shock period is over, we return to finding out how President Trump could affect the U.S. (and with it the global) healthcare...

x